Skip to content

Lanx Spinal Fixation System

by Lanx, LLC 3 variants

510(k) K120399

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK120399 Date9 Mar 2012ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
NKB
Device Class
Class II
Regulation
21 CFR Part 888.3070
Advisory Committee
Orthopedic
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Lanx Spinal Fixation System is a posterior spinal fixation device designed for non-cervical (T1–S2/ilium) pedicle and non-pedicle applications. It provides immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to spinal fusion. The system is intended for use in treating instabilities or deformities, including degenerative disc disease, through rigid fixation hardware. Constructs may incorporate pedicle screws, rods, and connectors to achieve segmental control.

The system is supplied as a modular assembly for surgical use in orthopedic settings, with components intended for single-use. It is not MRI-safe and requires sterile handling and proper storage as per manufacturer guidelines. Clearance under FDA 510(k) (K120399) confirms its regulatory status as substantially equivalent to a predicate device. No additional sterilization or reprocessing is specified; components are pre-packaged for immediate use.

Other devices from Lanx, Inc.

See all devices from Lanx, Inc. →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Lanx Spinal Fixation System used for?

    The Lanx Spinal Fixation System is designed for posterior spinal stabilization in skeletally mature patients, specifically for non-cervical segments (T1 through S2/ilium). It is intended as an adjunct to spinal fusion to address instabilities or deformities, such as those caused by degenerative disc disease. The system achieves segmental control through rigid fixation hardware, including pedicle screws, rods, and connectors, ensuring immobilization of affected spinal segments.

  • How is the Lanx Spinal Fixation System supplied, and is it single-use?

    The system is supplied as a modular assembly pre-packaged for immediate surgical use. Components are intended for single-use only, meaning they are not designed to be reprocessed or reused after a single surgical procedure. This ensures sterility and safety for each patient.

  • Does the Lanx Spinal Fixation System require any special handling or storage?

    Yes, the system requires sterile handling as per manufacturer guidelines due to its single-use nature. Proper storage conditions must be maintained to preserve sterility and functionality until use. The manufacturer provides specific storage instructions to ensure the system remains intact and ready for surgery.

  • Is the Lanx Spinal Fixation System MRI-safe?

    No, the Lanx Spinal Fixation System is explicitly stated as not MRI-safe. This means it should not be used in patients who require MRI imaging after surgery, as the device could interfere with the imaging process or pose risks during the scan.

  • What regulatory approval does the Lanx Spinal Fixation System hold?

    The Lanx Spinal Fixation System holds FDA 510(k) clearance under the reference number K120399. This clearance confirms that the device is substantially equivalent to a predicate device, meeting regulatory standards for safety and effectiveness as determined by the FDA.